In vitro and in vivo activities of clarithromycin against Mycobacterium avium
about
sameAs
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophagesExtracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complexEffect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complexActivity of azithromycin against Mycobacterium avium infection in beige miceActivities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophagesActivities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophagesTelithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatmentFirst randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutolTherapeutic efficacy of the benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbitsClarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige miceActivities of rifabutin, clarithromycin, and ethambutol against two virulent strains of Mycobacterium avium in a mouse modelEffectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse modelComparative activities of azithromycin and clarithromycin against Mycobacterium avium infection in beige miceMycobacterium avium strains resistant to clarithromycin and azithromycinMICs and MBCs of clarithromycin against Mycobacterium avium within human macrophagesAntituberculosis activity of clarithromycinSynergistic activities of clarithromycin and pyrazinamide against Mycobacterium tuberculosis in human macrophagesActivity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige miceAnticytomegaloviral activity of methotrexate associated with preferential accumulation of drug by cytomegalovirus-infected cellsHow effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice?Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige miceActivities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige miceEmergence of Mycobacterium avium populations resistant to macrolides during experimental chemotherapy.Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in miceSparfloxacin, ethambutol, and cortisol receptor inhibitor RU-40 555 treatment for disseminated Mycobacterium avium complex infection of normal C57BL/6 mice.Activities of azithromycin and clarithromycin against nontuberculous mycobacteria in beige mice.Azithromycin as treatment for disseminated Mycobacterium avium complex in AIDS patients.Perspective on animal models: chronic intracellular infections.Disseminated Mycobacterium avium-intracellulare in a kidney transplant recipient.Beige mouse model for Mycobacterium avium complex disease.Postantibiotic effect of clarithromycin alone and combined with ethambutol against Mycobacterium avium complexThe new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin.Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice.Inhibition of intracellular growth of Mycobacterium avium by one pulsed exposure of infected macrophages to clarithromycin.Pharmacokinetics, toxicity, and efficacy of liposomal capreomycin in disseminated Mycobacterium avium beige mouse modelActivities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organismsTherapy of Rhodococcus equi disseminated infections in nude mice.Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycinIn vitro and in vivo Evaluation of Synergism between Anti-Tubercular Spectinamides and Non-Classical Tuberculosis Antibiotics
P2860
Q28321761-67D83AD7-F5DE-4998-90A0-891F3776CD8EQ28326449-232EB88E-08EF-4209-A72A-D0D879897E52Q28326618-8B981BAA-13AD-48D8-A760-9EB2AD80196DQ28326884-EF57B56A-E4EC-4DF4-97D4-8468B67F0E62Q28326992-ABFD6CC3-4E6C-4BB9-9450-6FD6B61514B7Q28330701-5F1C9010-E1D0-4A9B-B2CD-B2409397AA9EQ28343803-D5079BAB-C74A-489B-AF6A-E2C713073567Q28350470-EF8AF201-6282-4E1E-B42F-4B896D36443CQ28368020-170CD2FE-0FE6-4744-B68C-F54662564CDBQ28368056-67210B3D-EDA7-439A-B7B7-CF7233C06C0CQ28368218-166C7A0C-9E30-4A4D-8E45-3625AA92E729Q28368450-172D4F4A-4BF1-488B-A04F-51A9788A78DEQ28369086-D460B869-CEA0-4C67-8465-26E71BFDA18FQ28369301-8D6886B3-4EA7-4709-A6B4-9EFE0D2D70D1Q28378654-AD42AE90-2158-4619-9FA9-785503D61346Q28378794-B4127658-C4A3-40CA-9E0F-2F37C26200D0Q28379126-1A25012E-ACA8-4AA9-A8FC-2C2C27C292AEQ28379176-3B7E4819-EADF-4B38-AC5D-FC96E6B8FECFQ28379178-4D708041-7D7A-4D3D-83F3-D566CD7FA277Q28379180-BA6F01EB-445D-49F4-9EA4-F9BC04BBB42FQ28379202-E00B7D86-F8E4-4305-BDF0-70B05EDC01B2Q28379216-81B28ADD-186A-4837-A2F4-F77983D434A2Q28379322-1C8B02D7-450D-47D0-87C2-8037BE5C5861Q28476689-782EF92E-9E1F-4D6F-9075-61D8A55EDA20Q33745057-48839C8D-69ED-44C2-8148-98D17FF32443Q33754030-E7370BF9-1651-484C-A7EE-D64EFF2170BFQ33978221-D40857EE-8676-4EA4-8016-B7406C5001ACQ34347914-084F61AB-5BC4-4B51-B263-0E0997DD8CEDQ34530430-141C89FA-2933-44D6-B11D-2E5CB03AEFA5Q35116742-11D47761-1CC7-488A-9923-63340436ACF4Q35121082-C0CECE01-AC4D-474F-A68D-CC3EC1C2ACEBQ35229174-C3A2A640-D596-427D-BF96-D8A103CA914AQ35811091-C2475BB3-1115-45DF-BFB6-08C6F719B8D3Q35816447-6EF757CF-E265-4AEC-9D0E-C8A6A0F84D87Q35822868-459ADABC-D78A-4188-907A-25A43D64B1E6Q35843595-08FB4D45-D160-40F1-8A2D-14BA13C98EF0Q35862691-92FF2E15-8DEB-4E77-B6E0-A839CC4CE624Q35885553-9C658203-43CF-4BE6-A080-E627FB23CD26Q35904249-AEB72DDB-3494-4BB6-BA2A-57A61D596814Q36056408-7F78B00D-175D-4A5F-8FA9-468ED30A444D
P2860
In vitro and in vivo activities of clarithromycin against Mycobacterium avium
description
1989 nî lūn-bûn
@nan
1989 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
In vitro and in vivo activities of clarithromycin against Mycobacterium avium
@ast
In vitro and in vivo activities of clarithromycin against Mycobacterium avium
@en
In vitro and in vivo activities of clarithromycin against Mycobacterium avium
@nl
type
label
In vitro and in vivo activities of clarithromycin against Mycobacterium avium
@ast
In vitro and in vivo activities of clarithromycin against Mycobacterium avium
@en
In vitro and in vivo activities of clarithromycin against Mycobacterium avium
@nl
prefLabel
In vitro and in vivo activities of clarithromycin against Mycobacterium avium
@ast
In vitro and in vivo activities of clarithromycin against Mycobacterium avium
@en
In vitro and in vivo activities of clarithromycin against Mycobacterium avium
@nl
P2093
P2860
P356
P1476
In vitro and in vivo activities of clarithromycin against Mycobacterium avium
@en
P2093
C W Hanson
D McDaniel
P B Fernandes
R N Swanson
P2860
P304
P356
10.1128/AAC.33.9.1531
P407
P577
1989-09-01T00:00:00Z